VRCA:NASDAQ, Verrica Pharmaceuticals Inc.

VRCA stock overview

Verrica Pharmaceuticals Inc. (VRCA:NASDAQ) closed at $3.58 on October 13, 2026, down 10.72% on the day. The stock trades 63.5% below its 52-week high of $9.82 and 9.1% above its 52-week low of $3.28. Over the past year, it lost 12.9%. Verrica Pharmaceuticals Inc. is part of the Health Care sector (Major Pharmaceuticals).

Key figures

Price: $3.58
Day change: -10.72%
Volume: 82,791
Average volume: 64,441
Market cap: 61M+
52-week range: $3.28 – $9.82
50-day average: $4.84
200-day average: $5.93

Performance

5D	1M	3M	6M	1Y
-12.90%	-25.10%	-35.61%	-43.35%	-12.90%

Price action over the past year

In 252 trading sessions since October 13, 2025, VRCA closed higher on 110 days (44%). Its best day was November 28, 2025 (+35.62%) and its worst was December 1, 2025 (-17.03%). The stock moved 10% or more in a single session 21 times. It opened at least 5% above the previous day's high 1 time.

Recent signals

Oct 13, 2026: Down 25.3% over 14 days, from $4.80 (Dips & Crashes scanner)
Oct 13, 2026: Hit a new 6-Month Low of $3.58 (New Highs/Lows scanner)

VRCA news

About Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc a clinical-stage medical dermatology company focused on identifying, developing and commercializing innovative pharmaceutical products for the treatment of skin diseases with significant unmet needs.

Similar stocks

Find more stocks like VRCA with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.